Nestlé said it has not confirmed any cases of illness or reported symptoms linked to the recalled products.
The company has nevertheless withdrawn certain batches of its major infant nutrition brands including SMA, BEBA, and NAN infant and follow-on formulas from dozens of countries across Europe, Africa, the Americas, and Asia, citing the potential presence of a toxin that could cause nausea and vomiting.
The recall, which initially began on a limited scale in December, marks another test for newly appointed Nestlé CEO Philipp Navratil, who is seeking to revive growth through a portfolio overhaul following a period of managerial upheaval.